Nivolumab, concentrate solution for infusion: 10 mg/mL, 1 x 4 mL vial, 10 mg/mL, 1 x 10 mL vial, Opdivo®, plus Ipilimumab, concentrate solution for infusion: 5 mg/mL, 1 x 40 mL vial, 5 mg/mL, 1 x 10 mL vial, Yervoy®, Bristol Myers Squibb

Page last updated: 18 April 2016

• Public Summary Document (PSD) November 2015 PBAC Meeting - (PDF 891KB)
• Public Summary Document (PSD) November 2015 PBAC Meeting - (Word 138KB)